Webinar on demand: Asthma & COPD - medical devices that will change your practice New Interim Order will permit import of alternate epinephrine autoinjector during EpiPen shortageAuvi-Q 0.3 mg autoinjector expected to be available in pharmacies by September 7th New, shorter therapy more effective for latent TB, landmark study finds Antimicrobial allergy: assessing and managing patients with hypersensitivity reactions Patients with cystic fibrosis doing better in Canada than elsewhere, study finds Getting influenza raises heart attack risk, especially in seniors: study Cardiovascular risk peaks 30 days after starting LABA or LAMA therapy in COPD Close monitoring for cardiovascular symptoms recommended for new users of LABAs or LAMAs Canadian Thoracic Society issues COPD pharmacotherapy update Provides evidence-based recommendations for pharmacologic management of COPD New Canadian Thoracic Society statement focuses on severe asthma Provides guidance on management, including the role of new and emerging therapies Four things pharmacists should question about respiratory therapy Canadian Thoracic Society focuses on unnecessary tests and treatments, to improve care and reduce waste First Previous 31 32 33 34 35 Next Last
